- Q3 2026 GAAP revenue increased to $560.4M vs $536M in prior-year period
- GAAP diluted EPS swung to positive $1.07 compared to a loss of -$0.14 year-over-year
- Reaffirmed FY2026 guidance, expecting results at the upper end of the target range
Why is $ICUI moving today? · SEC 8-K archive
$ICUI SEC Filing Alert & Real-Time AI Stock Impact Analysis
T0 SEO archive for $ICUI: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).
FAQ: $ICUI filing catalyst
Why did $ICUI trigger an AI stock catalyst alert?
$ICUI triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: ICU Medical Reports Q3 Turnaround to EPS $1.07, Reaffirms FY Guidance at High End. Key points: - Q3 2026 GAAP revenue increased to $560.4M vs $536M in prior-year period - GAAP diluted EPS swung to positive $1.07 compared to a loss of -$0.14 year-over-year - Reaffirmed FY2026 guidance, expecting results at the upper end of the target range
How did $ICUI stock react after the SEC filing?
After the SEC 8-K for $ICUI, observed market reaction: T0 price $167.65. Past moves do not guarantee future results.
Where can I get real-time $ICUI SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $ICUI via Telegram and the VIP Web Terminal from €10/month.